These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19570829)

  • 1. Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus.
    Iikuni N; Lourenço EV; Hahn BH; La Cava A
    J Immunol; 2009 Aug; 183(3):1518-22. PubMed ID: 19570829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory CD4+ T cells promote B cell anergy in murine lupus.
    Liu Y; Liu A; Iikuni N; Xu H; Shi FD; La Cava A
    J Immunol; 2014 May; 192(9):4069-73. PubMed ID: 24670801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells.
    Wu HY; Center EM; Tsokos GC; Weiner HL
    Lupus; 2009 Jun; 18(7):586-96. PubMed ID: 19433458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus.
    Geginat J; Vasco M; Gerosa M; Tas SW; Pagani M; Grassi F; Flavell RA; Meroni P; Abrignani S
    Semin Immunol; 2019 Aug; 44():101330. PubMed ID: 31735515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex-TFRs: A Missing Piece of the SLE Puzzle?
    Wei X; Zhang J; Zhou X
    Front Immunol; 2021; 12():662305. PubMed ID: 33897710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.
    Morita K; Okamura T; Inoue M; Komai T; Teruya S; Iwasaki Y; Sumitomo S; Shoda H; Yamamoto K; Fujio K
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8131-E8140. PubMed ID: 27911796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathology of T cells in systemic lupus erythematosus.
    Mak A; Kow NY
    J Immunol Res; 2014; 2014():419029. PubMed ID: 24864268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of FOXP3
    Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
    Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
    Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
    Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
    Schaier M; Gottschalk C; Uhlmann L; Speer C; Kälble F; Eckstein V; Müller-Tidow C; Meuer S; Mahnke K; Lorenz HM; Zeier M; Steinborn A
    Arthritis Res Ther; 2018 Dec; 20(1):278. PubMed ID: 30563559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.
    Wu HY; Quintana FJ; Weiner HL
    J Immunol; 2008 Nov; 181(9):6038-50. PubMed ID: 18941193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting Edge: Low-dose Recombinant IL-2 Treatment Prevents Autoantibody Responses in Systemic Lupus Erythematosus via Regulatory T Cell-independent Depletion of T Follicular Helper Cells.
    Santana S; Papillion A; Foote JB; Bachus H; León B; De Miguel C; Ballesteros-Tato A
    J Immunol; 2024 Oct; 213(8):1053-1060. PubMed ID: 39195194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
    Tsokos GC; Magrath IT; Balow JE
    J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Regulatory T Cell in Active Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-Analysis.
    Li W; Deng C; Yang H; Wang G
    Front Immunol; 2019; 10():159. PubMed ID: 30833946
    [No Abstract]   [Full Text] [Related]  

  • 15. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
    Valencia X; Yarboro C; Illei G; Lipsky PE
    J Immunol; 2007 Feb; 178(4):2579-88. PubMed ID: 17277168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T-cell levels in systemic lupus erythematosus patients: a meta-analysis.
    Zhu Y; Huang Y; Ming B; Wu X; Chen Y; Dong L
    Lupus; 2019 Apr; 28(4):445-454. PubMed ID: 30744525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
    Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
    Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-regulatory cells in systemic lupus erythematosus.
    La Cava A
    Lupus; 2008 May; 17(5):421-5. PubMed ID: 18490420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4(+)FoxP3(+) regulatory T-cells in human systemic lupus erythematosus.
    Suen JL; Chiang BL
    J Formos Med Assoc; 2012 Sep; 111(9):465-70. PubMed ID: 23021502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulatory T cells in systemic lupus erythematosus].
    Okamura T; Morita K; Fujio K; Yamamoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):69-77. PubMed ID: 25765691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.